M&A Deal Summary

Warburg Pincus Acquires Accriva Diagnostics

On November 4, 2010, private equity firm Warburg Pincus acquired test/measurement equipment company Accriva Diagnostics from Thoratec for 55M USD

Acquisition Highlights
  • This is Warburg Pincus’ 1st transaction in the Test/Measurement Equipment sector.
  • This is Warburg Pincus’ 45th largest (disclosed) transaction.
  • This is Warburg Pincus’ 99th transaction in the United States.
  • This is Warburg Pincus’ 22nd transaction in California.
Investment Fate
  • Accriva Diagnostics was sold to a strategic buyer in 2017.

M&A Deal Summary
Date 2010-11-04
Target Accriva Diagnostics
Sector Test/Measurement Equipment
Buyer(s) Warburg Pincus
Sellers(s) Thoratec
Deal Type Divestiture
Deal Value 55M USD

Target

Accriva Diagnostics

San Diego, California, United States
Accriva Diagnostics is a leader in hemostasis management and POC testing. Accriva develops, manufactures, and markets: Hemochron® and ProTime® POC coagulation systems; IRMA TruPoint® Blood Gas and Electrolyte systems; Avoximeter® CO-Oximetry systems; and Tenderfoot®, Tenderlett® and Surgicutt® skin incision products.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Warburg Pincus

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1966
PE ASSETS 83.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Warburg Pincus is a mega-sized, global private equity firm focused on investment opportunities across North America, Asia, and Europe. Warburg will consider investing at various company stages, from early-stage opportunities to distressed situations. Warburg Pincus is organized by industry groups. Verticals include financial services, healthcare, technology, media & telecommunications, energy, consumer & industrial, and real estate. Within financial services, Warburg will consider asset/wealth managers, banks, exchanges, financial technology, insurance, transaction processing, private banking, and specialty/consumer finance. Within healthcare, specific areas of interest include medical devices, healthcare services, and biotech/pharmaceuticals. Within technology/media/communications, Warburg targets software, media/internet/information, financial technology, telecom, business services, and systems/semiconductors. Within energy, specific areas of interest include oil/gas exploration, power generation/transmission, and alternative energy. Warburg Pincus raised its first fund in 1966 and is based in New York City.

DEAL STATS #
Overall 177 of 482
Sector (Test/Measurement Equipment) 1 of 1
Type (Divestiture) 7 of 20
State (California) 22 of 46
Country (United States) 99 of 237
Year (2010) 26 of 32
Size (of disclosed) 45 of 47
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-11-03 Gulf Coast Energy Resources

Houston, Texas, United States

Gulf Coast Energy Resources, LLC is a private-equity backed exploration and production company that was formed in 2010 and headquartered in Houston, Texas.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-11-10 RDA Microelectronics

Shanghai, China

RDA Microelectronics, Inc. is a fabless radio frequency (RF) semiconductor design company in China. RDA designs RF semiconductors to address a broad range of applications including 2G cellular, wireless local loop, and 3G cellular. RDA Microelectronics was founded in 2004 and is based in Shanghai, China.

Sell -

Seller(S) 1

SELLER

Thoratec

Pleasanton, California, United States
Category Company
Founded 1976
Sector Medical Products
Employees950
Revenue 503M USD (2013)
DESCRIPTION

Thoratec Corporation is a medical device company with a product portfolio for treating advanced heart failure patients. Thoratec develops, manufactures and markets proprietary medical devices used for circulatory support. Thoratec Corporation was established in 1976 and is headquartered in Pleasanton, California.

DEAL STATS #
Overall 1 of 1
Sector (Test/Measurement Equipment) 1 of 1
Type (Divestiture) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2010) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-01-25 Getinge-Heart Pump Technology

Sweden

Getinge-Heart Pump Technology, a minimally invasive, acute cardiac axial flow pump.

Buy $9M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-08-03 Levitronix-Medical Business

United States

Levitronix Medical is a provider of magnetically levitated, bearingless mechanical circulatory support products for cardiac and respiratory assist. CentriMag, Levitronix Medical's lead commercial product, is an extracorporeal, centrifugal flow blood pump used for short-term surgical support. Levitronix Medical also manufactures and markets an acute pediatric surgical support system, known as PediMag in the U.S. and PediVAS in international markets.

Buy $110M
Mergr

Product

Company

Legal